CD36 genotype and long-chain fatty acid uptake in the heart

Circulation Journal

Volumn 66, Issue 9, 2002, Pages 819-825

  Taigo, Kintaka ^a   Takao, Tanaka ^a   Makoto, Imai ^a   Itaru, Adachi ^b   Isamu, Narabayashi ^b   Yasushi, Kitaura ^a  

^a Third Division

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

CD36; Genotype; Long chain fatty acid uptake; Myocardium; Scintigraphy

Indexed keywords

CD36 ANTIGEN; DNA; LONG CHAIN FATTY ACID; MONOCLONAL ANTIBODY; FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID TRANSPORT; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENOTYPE; HEART DISEASE; HEART SCINTISCANNING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; PROTEIN EXPRESSION; WILD TYPE; EVALUATION; GENETICS; HEART; HEART MUSCLE; HETEROZYGOTE; METABOLISM; MIDDLE AGED; MUTATION; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; ANTIGENS, CD36; FATTY ACIDS; FEMALE; GENOTYPE; HEART; HEART DISEASES; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOCARDIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036729846     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.819     Document Type: Article

References (35)

1. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart
2. Prediction of functional outcome after acute myocardial infarction using BMIPP and Sestamibi scintigraphy
3. Cardiac SPECT with iodine-123 labeled fatty acids: Evaluation of myocardial viability with BMIPP
4. 201T1 myocardial single photon emission computed tomography: A multicenter trial
5. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog
6. 123I)-iodophenyl pentadecanoic acid single-photon emission computed tomography in cardiomyopathy
7. 123I-BMIPP uptake in the presence of a normal coronary angiogram and normokinetics on a left ventriculogram
8. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations
9. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation
10. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice
11. Isolation of myocardial membrane long-chain fatty acid-binding protein: Homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids
12. 478C→ T substitution (proline 90→serine) in CD36 cDNA accounts for CD36 deficiency
13. Genomic heterogeneity of type II CD36 deficiency
14. 123I-BMIPP in normal subjects
15. Myocardial scintigraphy using iodine-12315-(p-iodophenyl)-3-R, S-methylpentadecanoic acid predicts the response to β-blocker therapy in patients with dilated cardiomyopathy but does not reflect therapeutic effect
16. Family studies of type II CD36 deficient subjects: Linkage of a CD36 allele to a platelet-specific mRNA expression defect(s) causing type II CD36 deficiency
17. Isolation and partial characterization of an amphilic 56-kDa fatty acid binding protein from rat renal basolateral membrane
18. Photoaffinity labeling and fatty acid permeation in 3T3-L1 adipocytes
19. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein
20. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut
21. Effect of exercise induced hyperlactatemia on the biodistribution and metabolism of iodine-123-15(p-iodophenyl)-3-R,S-methyl pentadecanoic acid in normal volunteers
22. Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers
23. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy
24. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
25. CD36 deficiency has little influence on the pathophysiology of hypertrophic cardiomyopathy
26. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
27. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
28. Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency
29. Scintigraphic evidence for a specific long-chain fatty acid transporting system deficit and the genetic background in a patient with hypertrophic cardiomyopathy
30. Improvement in cardiac function and free fatty acid metabolism in a case of dilated cardiomyopathy with CD36 deficiency
31. CD36 deficiency associated with insulin resistance
32. Metabolic changes in human CD36 deficiency displayed by glucose loading
33. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats
34. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension
35. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia and myocardial hypertrophy